newsfilter
← Latest News
ACCESS Newswire·

Biophytis Obtains FDA Authorization to Initiate the SARA-31 Phase 3 Study in Sarcopenia

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / September 11,2023 / Biophytis SA , , a clinical-stage biotechnology company specialized in the development of